Jonathan A C Sterne

179.5k total citations · 28 hit papers
402 papers, 84.3k citations indexed

About

Jonathan A C Sterne is a scholar working on Infectious Diseases, Statistics and Probability and Statistics, Probability and Uncertainty. According to data from OpenAlex, Jonathan A C Sterne has authored 402 papers receiving a total of 84.3k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Infectious Diseases, 58 papers in Statistics and Probability and 55 papers in Statistics, Probability and Uncertainty. Recurrent topics in Jonathan A C Sterne's work include Meta-analysis and systematic reviews (53 papers), Health Systems, Economic Evaluations, Quality of Life (40 papers) and HIV/AIDS Research and Interventions (39 papers). Jonathan A C Sterne is often cited by papers focused on Meta-analysis and systematic reviews (53 papers), Health Systems, Economic Evaluations, Quality of Life (40 papers) and HIV/AIDS Research and Interventions (39 papers). Jonathan A C Sterne collaborates with scholars based in United Kingdom, Switzerland and United States. Jonathan A C Sterne's co-authors include Matthias Egger, Julian P. T. Higgins, Peter Jüni, Jelena Savović, David Moher, Kenneth F. Schulz, Roger Harbord, Laura Weeks, Doug Altman and Andrew D Oxman and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Jonathan A C Sterne

391 papers receiving 82.5k citations

Hit Papers

The Cochrane Collaboration's tool for assessing ri... 2000 2026 2008 2017 2011 2011 2009 2001 2007 5.0k 10.0k 15.0k 20.0k 25.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
    2011 26.4k citations Julian P. T. Higgins, Jelena Savović et al. profile →
  2. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
    2011 5.5k citations Jonathan A C Sterne, Julian P. T. Higgins et al. profile →
  3. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls
    2009 5.0k citations Jonathan A C Sterne, Angela Wood et al. profile →
  4. Funnel plots for detecting bias in meta-analysis
    2001 3.0k citations Jonathan A C Sterne, Matthias Egger profile →
  5. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
    2007 2.8k citations Jonathan A C Sterne, Nicholas J. Timpson et al. profile →
  6. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study
    2008 1.9k citations Matthias Egger, Jonathan A C Sterne et al. BMJ profile →
  7. Publication and related bias in meta-analysis
    2000 1.8k citations Jonathan A C Sterne, Matthias Egger et al. profile →
  8. Investigating and dealing with publication and other biases in meta-analysis
    2001 1.8k citations Jonathan A C Sterne, Matthias Egger et al. profile →
  9. A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints
    2005 1.7k citations Matthias Egger, Jonathan A C Sterne et al. profile →
  10. Essential Medical Statistics
    2014 1.3k citations Jonathan A C Sterne et al. profile →
  11. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
    2002 1.2k citations Matthias Egger, Margaret May et al. profile →
  12. Sifting the evidence---what's wrong with significance tests? Another comment on the role of statistical methods
    2001 1.0k citations Jonathan A C Sterne profile →
  13. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study
    2003 980 citations Matthias Egger, Jonathan A C Sterne et al. Health Technology Assessment profile →
  14. Metan: Fixed- and Random-Effects Meta-Analysis
    2008 890 citations Jonathan A C Sterne et al. profile →
  15. A revised tool for assessing risk of bias in randomized trials
    2016 858 citations Julian P. T. Higgins, Jonathan A C Sterne et al. profile →
  16. Using multiple genetic variants as instrumental variables for modifiable risk factors
    2011 787 citations Nicholas J. Timpson, Jonathan A C Sterne et al. profile →
  17. Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials
    2012 768 citations Jelena Savović, Nicky J. Welton et al. profile →
  18. Direction and impact of language bias in meta-analyses of controlled trials: empirical study
    2002 682 citations Jonathan A C Sterne, Matthias Egger et al. International Journal of Epidemiology profile →
  19. Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials
    2013 656 citations Punam Mangtani, Ibrahim Abubakar et al. profile →
  20. A unification of models for meta-analysis of diagnostic accuracy studies
    2006 599 citations Matthias Egger, Penny Whiting et al. profile →
  21. GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence
    2018 564 citations Jonathan A C Sterne, Julian P. T. Higgins et al. profile →
  22. Funnel Plots in Meta-analysis
    2004 543 citations Jonathan A C Sterne et al. profile →
  23. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.
    2012 519 citations Jelena Savović, Nicky J. Welton et al. Health Technology Assessment profile →
  24. Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review
    2016 455 citations Julian P. T. Higgins, José A López-López et al. BMJ profile →
  25. Accounting for missing data in statistical analyses: multiple imputation is not always the answer
    2019 427 citations Jonathan A C Sterne, Kate Tilling et al. International Journal of Epidemiology profile →
  26. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
    2017 381 citations José A López-López, Jonathan A C Sterne et al. BMJ profile →
  27. Association Between Risk-of-Bias Assessments and Results of Randomized Trials in Cochrane Reviews: The ROBES Meta-Epidemiologic Study
    2017 278 citations Jelena Savović, Julian P. T. Higgins et al. American Journal of Epidemiology profile →
  28. Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews
    2016 266 citations Jelena Savović, Jonathan A C Sterne et al. profile →

Peers

Jonathan A C Sterne
Comparison fields: 5 of 231
  • Surgery 13.3k
  • Epidemiology 12.0k
  • Public Health, Environmental and Occupational Health 9.2k
  • Pulmonary and Respiratory Medicine 8.7k
  • Physiology 7.9k
Replace Jonathan J Deeks with:
Jonathan J Deeks United Kingdom
Jos Kleijnen United Kingdom
Erik von Elm Switzerland
Cynthia D. Mulrow United States
A. Liberati Italy
Holger J. Schünemann Canada
Mike Clarke United Kingdom
Jan P. Vandenbroucke Netherlands
Kenneth F. Schulz United States
Simon G. Thompson United Kingdom
Jonathan J Deeks United Kingdom View profile →
Citations per field, relative to Jonathan A C Sterne
Jonathan A C Sterne · 1×
Citations per year, relative to Jonathan A C Sterne
Jonathan A C Sterne · 1×

Countries citing papers authored by Jonathan A C Sterne

Since Specialization
Citations

This map shows the geographic impact of Jonathan A C Sterne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan A C Sterne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan A C Sterne more than expected).

Fields of papers citing papers by Jonathan A C Sterne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan A C Sterne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan A C Sterne. The network helps show where Jonathan A C Sterne may publish in the future.

Co-authorship network of co-authors of Jonathan A C Sterne

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan A C Sterne. A scholar is included among the top collaborators of Jonathan A C Sterne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan A C Sterne. Jonathan A C Sterne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Transparent reporting of observational studies emulating a target trial: the TARGET Statement
2025 ·BMJ ·Aidan G Cashin, Harrison J Hansford, Miguel A. Hernán, Sonja A. Swanson, Hopin Lee, Matthew D. Jones, Issa J Dahabreh, Barbra A. Dickerman, Matthias Egger, Xabier García‐Albéniz, Robert Golub, Nazrul Islam, Sara Lodi, Margarita Moreno‐Betancur, Sallie‐Anne Pearson, Sebastian Schneeweiß, Melissa K. Sharp, Jonathan A C Sterne, Elizabeth A. Stuart, James H. McAuley
3
2
Risks of major arterial and venous thrombotic diseases after hospitalisation for influenza, pneumonia, and COVID-19: A population-wide cohort in 2.6 million people in Wales
2024 ·Thrombosis Research ·Spencer Keene, Hoda Abbasizanjani, Fatemeh Torabi, Rochelle Knight, Venexia Walker, Elena Raffetti, Geneviève Cézard, Samantha Ip, Alexia Sampri, Thomas Bolton, Rachel Denholm, Kamlesh Khunti, Ashley Akbari, Jennifer K Quint, Spiros Denaxas, Cathie Sudlow, Emanuele Di Angelantonio, Jonathan A C Sterne, Angela Wood, William Whiteley
6
3
HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis
2023 ·The Lancet HIV ·(unknown), Stefanie Hossmann, Suzanne M Ingle, Hajra Okhai, Katharina Kusejko, Johannes P. Mouton, Pantxika Bellecave, Ard van Sighem, Melanie Stecher, Antonella d’Arminio Monforte, M. John Gill, Caroline Sabin, Gary Maartens, Huldrych F. Günthard, Jonathan A C Sterne, Richard Lessells, Matthias Egger, Roger D. Kouyos
52
4
All-cause hospitalisation among people living with HIV according to gender, mode of HIV acquisition, ethnicity, and geographical origin in Europe and North America: findings from the ART-CC cohort collaboration
2023 ·The Lancet Public Health ·(unknown), Fiona Lampe, Suzanne M Ingle, Jonathan A C Sterne, Adam Trickey, M. John Gill, Vasileios Papastamopoulos, Linda Wittkop, Marc van der Valk, Maria Kitchen, Jodie L. Guest, Derek D. Satre, Gilles Wandeler, (unknown), Jessica L. Castilho, Heidi M. Crane, Colette Smith
4
5
Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study
2023 ·The Lancet Regional Health - Europe ·Edward P K Parker, Elsie Horne, William Hulme, John Tazare, Bang Zheng, Edward J Carr, Fiona Loud, (unknown), Viyaasan Mahalingasivam, Brian MacKenna, Amir Mehrkar, (unknown), Shalini Santhakumaran, Retha Steenkamp, Ben Goldacre, Jonathan A C Sterne, Dorothea Nitsch, Laurie A. Tomlinson
8
6
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies
2023 ·Health Technology Assessment ·Jessica Harris, Koen B. Pouwels, Tom Johnson, Jonathan A C Sterne, (unknown), (unknown), Barnaby C Reeves, Umberto Benedetto, Yoon K. Loke, Daniel Lasserson, Brett Doble, (unknown), Sabi Redwood, Sarah Wordsworth, Andrew Mumford, Chris Rogers, Maria Pufulete
6
7
Inequality in uptake of bowel cancer screening by deprivation, ethnicity and smoking status: cross-sectional study in 86 850 citizens
2023 ·Journal of Public Health ·(unknown), Sam Creavin, (unknown), Jonathan A C Sterne, Joanna G Williams
6
8
Characterising patterns of COVID-19 and long COVID symptoms: evidence from nine UK longitudinal studies
2023 ·European Journal of Epidemiology ·Ruth C. E. Bowyer, Charlotte F. Huggins, Renin Toms, Richard Shaw, Bo Hou, Ellen J. Thompson, Alex S. F. Kwong, Dylan M. Williams, Milla Kibble, George B. Ploubidis, Nicholas J. Timpson, Jonathan A C Sterne, Nish Chaturvedi, Claire J. Steves, Kate Tilling, Richard J. Silverwood, (unknown)
18
9
Estimating the Effectiveness of First Dose of COVID-19 Vaccine Against Mortality in England: A Quasi-Experimental Study
2022 ·American Journal of Epidemiology ·Charlotte Bermingham, Jasper Morgan, Daniel Ayoubkhani, Myer Glickman, Nazrul Islam, Aziz Sheikh, Jonathan A C Sterne, Andrew Walker, Vahé Nafilyan
7
10
Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England
2022 ·PLoS Medicine ·William Whiteley, Samantha Ip, Jennifer Cooper, Thomas Bolton, Spencer Keene, Venexia Walker, Rachel Denholm, Ashley Akbari, (unknown), Sam Hollings, Emanuele Di Angelantonio, Spiros Denaxas, Angela Wood, Jonathan A C Sterne, Cathie Sudlow
51
11
Time to reconsider the role of ribavirin in Lassa fever
2021 ·PLoS neglected tropical diseases ·Alex P. Salam, Hung‐Yuan Cheng, Tansy Edwards, Piero Olliaro, Jonathan A C Sterne, Peter Horby
29
12
Health System‐Based Unhealthy Alcohol Use Screening and Treatment Comparing Demographically Matched Participants With and Without HIV
2020 ·Alcoholism Clinical and Experimental Research ·Michael J. Silverberg, (unknown), (unknown), Alexandra Anderson, Stacey Alexeeff, Jennifer O. Lam, Sally Slome, Jason Flamm, C. Bradley Hare, Thekla B. Ross, Amy C. Justice, Jonathan A C Sterne, Andrew E. Williams, Kendall Bryant, Constance Weisner, Michael A. Horberg, Stacy Sterling, Derek D. Satre
13
13
The Cost-Effectiveness Of Novel Oral Anticoagulants For The Prevention Of Stroke In Atrial Fibrillation In England And Wales
2015 ·Value in Health ·Howard Thom, William Hollingworth, (unknown), Jonathan A C Sterne, (unknown), Philippa Davies, José A López-López, (unknown), Deborah M Caldwell, Sofia Dias, Diane Eaton, Julian P. T. Higgins, Chris Salisbury, Jelena Savović, Reecha Sofat, Annya Stephens-Boal, Aroon D. Hingorani, Nicky J. Welton
2
14
Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette–Guérin vaccination against tuberculosis
2013 ·Health Technology Assessment ·Ibrahim Abubakar, Laura Pimpin, Cono Ariti, Rhys Beynon, Punam Mangtani, Jonathan A C Sterne, (unknown), Peter G. Smith, Marc Lipman, David Elliman, (unknown), Lydia N. Drumright, Penny Whiting, Emilia Vynnycky, Laura C. Rodrigues
344
15
The Coding Causes of Death in HIV (CoDe) Project
2011 ·Epidemiology ·Justyna Kowalska, Nina Friis‐Møller, Ole Kirk, Wendy Bannister, Amanda Mocroft, Caroline Sabin, Peter Reiss, M. John Gill, Charlotte Lewden, Andrew Phillips, Antonella d’Arminio Monforte, Matthew Law, Jonathan A C Sterne, Stéphane De Wit, Jens Lundgren
111
16
A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men
2007 ·International Journal of Epidemiology ·Margaret May, Jonathan A C Sterne, M Shipley, Eric J. Brunner, Ralph B. D’Agostino, Peter H. Whincup, Yoav Ben‐Shlomo, Andrew Carr, Bruno Ledergerber, Jens Lundgren, A. N. Phillips, Joseph M. Massaro, Matthias Egger
19
17
Opportunistic and systematic screening for chlamydia: a study of consultations by young adults in general practice.
2006 ·PubMed ·Chris Salisbury, John Macleod, Matthias Egger, Anne McCarthy, Rita Patel, Aisha Holloway, Fowzia Ibrahim, Jonathan A C Sterne, Paddy Horner, Nicola Low
39
18
Corrections to the meta-analysis command
1999 ·Stata technical bulletin ·Stephen Sharp, Jonathan A C Sterne
11
19
[Blood sugar-lowering effect of 1,1-dimethylbiguanide].
1958 ·PubMed ·Jonathan A C Sterne
18
20
[Three cases of Takayashu's disease in Morocco].
1956 ·PubMed ·Jonathan A C Sterne
0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan J Deeks Breakdown of academic impact, for papers by Jos Kleijnen Breakdown of academic impact, for papers by Erik von Elm Breakdown of academic impact, for papers by Cynthia D. Mulrow Breakdown of academic impact, for papers by A. Liberati Breakdown of academic impact, for papers by Holger J. Schünemann Breakdown of academic impact, for papers by Mike Clarke Breakdown of academic impact, for papers by Jan P. Vandenbroucke Breakdown of academic impact, for papers by Kenneth F. Schulz Breakdown of academic impact, for papers by Simon G. Thompson
Rankless by CCL
2026